Biogen's Early-Stage Alzheimer's Data Continues to Impress Post author:Sam Post published:November 1, 2017 Post category:BioPharma ALZ’s researchers continue to see hope in Biogen’s aducanumab. Source: BioSpace You Might Also Like This CRISPR Startup Co-Founded by a 30-Year-Old Just Nabbed $38 Million for Pig-to-Human Transplants March 15, 2017 Aptinyx Bags $70M Financing to Fuel Expanding Pipeline December 17, 2017 Galera Therapeutics Doses First Patient in Pancreatic Cancer Trial February 27, 2018
This CRISPR Startup Co-Founded by a 30-Year-Old Just Nabbed $38 Million for Pig-to-Human Transplants March 15, 2017
